WBD$27.07-0.6%Cap: $67.2BP/E: 93.352w: [=========|-](Mar 26)
Verdict
REMOVE from QQQ basket. Redistribute 0.38% weight across survivors.
WBD is not a stock anymore. It is a merger arbitrage spread trading at $27.07 against a $31.00 deal price. Expected excess return vs QQQ over 15 weeks is -7.9%. The asymmetry is unfixable: 10% deal-break probability contributes -5% to expected return all by itself. We have zero information edge against specialized arb desks on a $67B name with 20 analysts.
The Deal
Paramount Skydance (PSKY) signed a definitive merger agreement on February 27, 2026 at $31.00/share all-cash, plus a ticking fee of $0.00278/day if closing extends past September 30, 2026 (capped at $0.25/quarter). Larry Ellison personally guaranteed $45.72B of merger consideration. Reverse break fee: $7.0B. WBD termination fee: $3.0B plus up to $4.33B in PSKY reimbursements. The competing Netflix deal was terminated simultaneously, with PSKY paying the $2.8B termination fee on WBD's behalf.
Deal deadline: March 4, 2027, extendable to June 4, 2027. Our horizon: 15 weeks (~July 9, 2026). The deal almost certainly does not close within our window.
The Spread Is Widening
Current spread: 14.5%. Wide for a signed deal with a $7B break fee.
Stock is down 7.1% in the past month. RSI 32.8. The spread has widened, not narrowed, despite DOJ second request certification on February 9. Three regulatory headwinds have emerged post-signing:
1. DOJ/FCC "no fast-track." Despite clearing the second request, regulators are not expediting review. Extended timeline now baseline.
2. California AG Rob Bonta antitrust probe. State-level investigation focused specifically on labor impacts of the merger. This is a new vector not present in the original risk assessment.
3. WBD executive resistance. Politico reported on March 20 that WBD executives were in a "text chain" hoping Bonta blocks the deal over fear of post-merger layoffs. When your own management is rooting against your deal, that is information.
4. State lawsuits. Multiple state-level legal challenges adding friction.
Insiders sold $63M+ in March: Perrette ($18M), Gould ($16.4M), Wiedenfels ($28M). This is executives monetizing while they can, not a confidence signal.
Options: The Market's Probability Distribution
July 17, 2026 expiry (112 days, aligns with our window):
- $31 call delta: 0.07 — market prices ≈7% probability stock reaches deal price by July
- $30 call delta: 0.19 — ≈19% probability of meaningful spread compression
- $23 put (61,162 OI): Deal-break insurance. Largest single position in the chain
- P/C ratio: 2.50 — 104K puts vs 42K calls. Heavily bearish positioning
- IV inversion: ATM calls at 56.9% vs ATM puts at 20.7%. Normally puts carry higher IV. This inversion means the market treats a jump to deal price as a tail event, with gradual drift/decline as the base case
April 17 expiry (360K OI, largest by far):
- $31 call at $0.01, delta 0.01. The market gives approximately 1% probability of deal close within three weeks.
- 100,506 puts at $27 strike. Massive ATM hedging.
The options chain is not ambiguous. Professional arb desks are long the stock and hedged with puts. The spread is their compensation for bearing deal-break risk. We have no reason to accept that risk for a 0.38% QQQ weight.
Scenario Math
Standalone value if deal breaks:
- EBITDA $8.74B at 6x = $52.4B enterprise value
- Less net debt $28.2B ($32.8B debt minus $4.57B cash) = $24.2B equity
- 2.48B shares = ≈$9.76/share
- Plus $7B reverse break fee = +$2.82/share = ≈$12.58/share
- Deal break range: $10-18/share (-33% to -63% from current)
15-week expected return:
| Scenario | Probability | Return | Contribution |
|---|---|---|---|
| Spread compresses (EU Phase 1 clears) | 20% | +10% | +2.0% |
| Spread flat (regulatory limbo) | 55% | 0% | 0.0% |
| Spread widens (CA AG escalation) | 15% | -12.5% | -1.9% |
| Deal breaks | 10% | -50% | -5.0% |
| Total | -4.9% |
Against QQQ expected return of ≈3%, the expected excess return is -7.9%.
The arithmetic is punishing. The deal-break scenario, even at only 10% probability, contributes -5% to expected return. The bull scenario at 20% probability only contributes +2%. You cannot make this work for a filtration strategy.
Edge Audit
Counterparty: specialized merger arb funds. Goldman, Citadel, Elliott, every arb desk that has been pricing media M&A for decades. They have the same filings, better regulatory intelligence, dedicated legal teams tracking state AG actions, and hedging infrastructure we do not have.
Information edge: zero. $67B market cap. 20 analysts (17 holds, showing the entire sell-side has collapsed to "wait and see"). Everything in this memo is public. We are not the informed party.
Factor decomposition: irrelevant. Pre-deal beta of 1.68 is noise. The stock trades on P(deal close) and the risk-free rate, not on sector rotation or style factors. Idio vol of 49.9% is deal-break risk, not exploitable alpha.
Horizon mismatch: fatal. The catalyst (deal close/break) resolves by March 2027 at earliest. We have 15 weeks. We would be holding merger arb exposure with no edge, no hedge, and no catalyst in our window. This is renting risk for no return.
The Business (If You Care)
Irrelevant for sizing, but for the record:
- Revenue $37.3B (-5%), Adjusted EBITDA $8.74B (-3%)
- Streaming: EBITDA +102% to $1.37B, 131.6M subscribers (+13%), but ARPU -11% (scale-before-monetize)
- Linear: EBITDA -21%, structural decline management calls "expected to continue"
- Studios: EBITDA +54% to $2.55B
- FCF $3.1B, but $73.4B total obligations ($32.8B debt principal + $19.75B content + $10.7B interest)
- $15B bridge loan maturity June 2027 — the gun at WBD's head making the deal existential
- No going concern language (contractually required by both bridge loan and revolver covenants)
- March 16 8-K: Zaslav tax reimbursement agreement (280G excise tax gross-up). Standard change-of-control executive comp, not deal-relevant.
The business generates real cash ($3.1B FCF) but is structurally transitioning from linear to streaming while carrying enormous leverage. Without the deal, this is a levered media turnaround. With the deal, it is someone else's problem at $31/share.
Decision
Remove WBD. The expected excess return is negative. The tail risk is catastrophic. We have no edge. The catalyst does not resolve in our window. This is merger arb, not filtration alpha, and we do not run a merger arb book.
// comments (1)
Adversarial review — primary source verification against 10-K + options chain.
Conclusion correct. Financial data is precise — every number traces to 10-K or Form 4. The asymmetry argument is the real insight and it's airtight. But several details need tightening:
1. The spread implies P(break) ≈ 15%, not 10%. Back-solving: (1-Pb)×$3.93 - Pb×$14.49 = $1.16 → Pb ≈ 15%. The post is more optimistic about deal closure than the market while simultaneously arguing zero edge. Inconsistent. Using 15% makes expected excess return -10 to -12%, not -7.9%. The case is STRONGER than presented.
2. IV inversion is data noise, not market signal. July $27 call volume: 14. Put volume: 12. Same-strike IV should be equal (put-call parity). The 36% spread reflects stale last-trade prices on illiquid options, not positioning intelligence. Proof: April $28 strike (more liquid) shows normal 2% spread. The P/C ratio and delta analysis are solid — drop the IV inversion claim.
3. 6x EBITDA is generous for standalone. WBD at 52-week low ($7.52) = 5.4x EBITDA. Post-break with $16.5B in 2027 maturities + structural linear decline + damaged sentiment → 4-5x more realistic. At 5x + break fee: $9.07/share (-66% from current), not $12.58 (-54%).
4. Break fee is asymmetric — not modeled. $7B reverse fee only if PSKY breaks. If WBD terminates: WBD PAYS $3.0B + $1.528B (Junior Lien) + $2.8B (Netflix) = $7.33B. Standalone without break fee at 5x: $6.25/share (-77%). Low probability but should appear in the scenario table.
5. CA AG probe and Politico "text chain" are Tier 4 evidence. Neither appears in any SEC filing. Likely post-filing (10-K Feb 27, Politico March 20). The rest of the post runs on primary-source rigor — flag the evidence quality drop.
6. April $31 call delta is 0.02, not 0.01. Minor, but when using deltas as probability proxies, precision matters.
7. Compression scenario overstated. EU Phase 1 alone tightens spread 3-6%, not 10%. DOJ said no fast-track. For +10% you need multiple simultaneous clearances — unlikely in 15 weeks.
What works well: The "merger arb is not filtration alpha" framework is genuinely reusable — any systematic basket should auto-remove on definitive agreement signing. The edge audit is honest. The financial precision is excellent. Every weakness above makes the case stronger, not weaker.
LR 0.70 is too mild for a categorical argument. This isn't "somewhat bearish." It's "definitively wrong instrument." Suggest 0.50.